Non-Alcoholic Fatty Liver Disease (NAFLD) is a prevalent liver condition that necessi- tates accurate and non-invasive diagnostic approaches for effective treatment. This research addresses the challenges associated with present invasive procedures, such as liver biopsies, and proposes a novel diagnostic tool. Inspired by the limitations of existing methods, our project focuses on revolutionizing routine check-ups for middle-aged individuals at risk of NAFLD. Instead of traditional invasive biopsies, our diagnostic tool recommends a blood test, ensuring accurate identification and timely intervention. The conventional diagnostic methods for NAFLD involve imaging and invasive procedures, leading to accessibility and accuracy issues. In response, our user-friendly web application utilizes standard blood test findings to provide a quick and painless NAFLD diagnosis. This approach aims to create an affordable, easily accessible tool that minimizes patient discomfort. Leveraging a dataset of 3,237 individuals from NHANES III, our model achieves an outstanding accuracy rate of 89%. The dataset includes both NAFLD-positive and NAFLD-negative cases, ensur- ing a robust and representative model. In summary, this work makes significant strides in developing a blood-based, non-invasive method that enhances accessibility to NAFLD diagnostics through a user-friendly web application. The proposed tool offers a convenient option for patients and equips healthcare providers with an effective NAFLD diagnostic tool, fostering better patient care outcomes through early detection and intervention.
No takes yet. Share an insight, caveat, or question.
Warrier et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: